2016
Official American Thoracic Society Clinical Practice Guidelines: Diagnostic Evaluation of Infants with Recurrent or Persistent Wheezing
Ren CL, Esther CR, Debley JS, Sockrider M, Yilmaz O, Amin N, Bazzy-Asaad A, Davis SD, Durand M, Ewig JM, Yuksel H, Lombardi E, Noah TL, Radford P, Ranganathan S, Teper A, Weinberger M, Brozek J, Wilson KC. Official American Thoracic Society Clinical Practice Guidelines: Diagnostic Evaluation of Infants with Recurrent or Persistent Wheezing. American Journal Of Respiratory And Critical Care Medicine 2016, 194: 356-373. PMID: 27479061, DOI: 10.1164/rccm.201604-0694st.Peer-Reviewed Original ResearchMeSH KeywordsHumansInfantInfant, NewbornRecurrenceRespiratory Function TestsRespiratory SoundsSocietiesUnited StatesConceptsGrading of RecommendationsPersistent wheezingConditional recommendationEvidence synthesisDiagnostic evaluationClinical questionsFood avoidanceInfant pulmonary function testingLow-quality evidenceUpper gastrointestinal radiographyPulmonary function testingEvaluation of infantsGuideline development committeeAmerican Thoracic SocietyPaucity of evidenceStandard therapyAllergy testingBronchoalveolar lavageCase seriesClinical outcomesGastrointestinal radiographyAdditional researchFunction testingPatient populationGastrointestinal scintigraphyBiochemical Screening for Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia
Montgomery AM, Bazzy-Asaad A, Asnes JD, Bizzarro MJ, Ehrenkranz RA, Weismann CG. Biochemical Screening for Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia. Neonatology 2016, 109: 190-194. PMID: 26780635, DOI: 10.1159/000442043.Peer-Reviewed Original ResearchConceptsBronchopulmonary dysplasiaPulmonary hypertensionGestational ageNT-proBNPBirth weightBiochemical markersPreterm infantsN-terminal pro-B-type natriuretic peptidePro-B-type natriuretic peptidePresence of PHCross-sectional pilot studyNitric oxideWeeks gestational ageSuch biochemical markersEchocardiographic evidenceScreening echocardiogramsWeeks CGANatriuretic peptideCitrulline levelsInfantsArginine levelsPrecursor citrullineLarger studyEchocardiogramPilot study
2008
A Role for Macrophage Migration Inhibitory Factor in the Neonatal Respiratory Distress Syndrome
Kevill KA, Bhandari V, Kettunen M, Leng L, Fan J, Mizue Y, Dzuira JD, Reyes-Mugica M, McDonald CL, Baugh JA, O’Connor C, Aghai ZH, Donnelly SC, Bazzy-Asaad A, Bucala RJ. A Role for Macrophage Migration Inhibitory Factor in the Neonatal Respiratory Distress Syndrome. The Journal Of Immunology 2008, 180: 601-608. PMID: 18097062, DOI: 10.4049/jimmunol.180.1.601.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsBronchopulmonary DysplasiaCorticosteroneDisease Models, AnimalHumansInfant, NewbornIntramolecular OxidoreductasesLungMacrophage Migration-Inhibitory FactorsMiceMice, KnockoutNeovascularization, PhysiologicPneumoniaPulmonary Surfactant-Associated ProteinsRespiratory Distress Syndrome, NewbornVascular Endothelial Growth Factor AConceptsMacrophage migration inhibitory factorRespiratory distress syndromeNeonatal respiratory distress syndromeMigration inhibitory factorEmbryonic day 18Lung maturationDistress syndromeHuman neonatesDay 18Inhibitory factorEarly saccular stageLungs of pupsNewborn lung diseaseFetal lung maturationVascular endothelial growth factorEmbryonic day 19.5Pulmonary epithelial cellsEndothelial growth factorMIF deficiencyMIF levelsWild-type controlsBronchopulmonary dysplasiaLung diseasePulmonary developmentHistological evaluation